Low-dose cyclophosphamide depletes circulating na？ve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy

DOI: 10.1080/2162402X.2018.1474318

Keywords: Malignant pleural mesothelioma, DC vaccination, cyclophosphamide, regulatory T cells, cytotoxic T cells

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text